ERIN LOVEWELL: Open Payments
NPI 1942452560 · MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 123 payments from 23 companies in 2025. Trend: 2023 $1,561 · 2024 $2,126 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $473 |
| AstraZeneca Pharmaceuticals LP | 9 | $246 |
| PFIZER INC. | 23 | $165 |
| Amgen Inc. | 11 | $146 |
| Lilly USA, LLC | 9 | $123 |
| SHIELD THERAPEUTICS INC | 5 | $114 |
| Kowa Pharmaceuticals America, Inc. | 7 | $108 |
| Abbott Laboratories | 5 | $102 |
| Novo Nordisk Inc | 4 | $66 |
| SANOFI-AVENTIS U.S. LLC | 1 | $38 |
Products named: VRAYLAR, QULIPTA, BREZTRI, ACCRUFER, UBRELVY, AIRSUPRA, ZORYVE, MOUNJARO.
Industry payments across KS — which companies pay providers there.
